Imexpharm (STC:IMP) Other Current Payables: ₫76,696 Mil (As of Mar. 2026)


STC:IMP Imexpharm Corp STC:IMP
98 GF Score
Price ₫41,200.00
GF Value ₫52,038.85
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm Other Current Payables?

Imexpharm STC:IMP 98 Other Current Payables is ₫76,696 Mil as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 98/100 and a GF Value™ of ₫52,038.85 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Imexpharm's Other Current Payables for the quarter that ended in Mar. 2026 was ₫76,696 Mil.

Imexpharm's quarterly Other Current Payables declined from Sep. 2025 (₫83,693 Mil) to Dec. 2025 (₫27,771 Mil) but then increased from Dec. 2025 (₫27,771 Mil) to Mar. 2026 (₫76,696 Mil).

Imexpharm's annual Other Current Payables declined from Dec. 2023 (₫77,979 Mil) to Dec. 2024 (₫20,349 Mil) but then increased from Dec. 2024 (₫20,349 Mil) to Dec. 2025 (₫27,771 Mil).

Imexpharm Other Current Payables Related Terms

Imexpharm Other Current Payables Historical Data

* Premium members only.

The historical data trend for Imexpharm's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Other Current Payables Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40,968.38 78,354.69 77,978.51 20,349.19 27,771.12

Imexpharm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89,972.73 187,479.90 83,692.75 27,771.12 76,696.12
STC:IMP
98GF Score
Imexpharm Corp STC:IMP
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₫76,696 Mil mean?
Imexpharm (STC:IMP) has a Other Current Payables of ₫76,696 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Imexpharm and its competitors.
Is Imexpharm's Other Current Payables too high?
Imexpharm's current Other Current Payables is ₫76,696 Mil. Overall, Imexpharm has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Other Current Payables compare to ZTS and UTHR?
Imexpharm's Other Current Payables of ₫76,696 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Imexpharm and its competitors. Imexpharm's current Other Current Payables is ₫76,696 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫52,038.85, compared to a current price of ₫41,200.00 — trading 20.8% below its estimated fair value. The current Other Current Payables is ₫76,696 Mil. Imexpharm's overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Other Current Payables is ₫76,696 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫41,200.00 is trading 20.8% below its estimated GF Value™ of ₫52,038.85. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Other Current Payables: ₫76,696 Mil
  • GF Value™: ₫52,038.85 vs. price of ₫41,200.00 (20.8% below fair value)
  • GF Score™: 98/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
98GF Score

Get the complete analysis for STC:IMP

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫41,200.00
Price
₫52,038.85
GF Value